<?xml version="1.0"?>
<case>
<name>Sunnyfield Association v Cronk [2009] FCA 33 (28 January 2009)</name>
<AustLII>http://www.austlii.edu.au/au/cases/cth/FCA/2009/33.html</AustLII>
<citphrases>
<citphrase id="cp1.0" type=cited from="[2005] FCA 344">patents</citphrase>
<citphrase id="cp1.1" type=cited from="[2005] FCA 344">invention claimed for a method of detection and treatment of malignant and non-malignant lesions by photochemotherapy</citphrase>
<citphrase id="cp1.2" type=cited from="[2005] FCA 344">whether patent invalid on grounds of obviousness, lack of novelty, lack of sufficiency and best method, lack of definition or lack of fair basis</citphrase>
<citphrase id="cp1.3" type=cited from="[2005] FCA 344">whether the patent is infringed in substance by a variant that does not have a material effect on the way the invention works</citphrase>
<citphrase id="cp1.4" type=cited from="[2005] FCA 344">consideration of the principles to be applied in determining a claim of infringement in substance when no claim is infringed on a textual approach to construction of the patent</citphrase>
<citphrase id="cp2.0" type=cited from="[2004] HCA 58">lockwood security products pty ltd v doric products pty ltd  patents</citphrase>
<citphrase id="cp2.1" type=cited from="[2004] HCA 58">validity</citphrase>
<citphrase id="cp2.2" type=cited from="[2004] HCA 58">fair basing of claims</citphrase>
<citphrase id="cp2.3" type=cited from="[2004] HCA 58">patent for a door lock</citphrase>
<citphrase id="cp2.4" type=cited from="[2004] HCA 58">specification included a consistory clause and described a preferred embodiment</citphrase>
<citphrase id="cp2.5" type=cited from="[2004] HCA 58">central claim essentially repeated consistory clause</citphrase>
<citphrase id="cp2.6" type=cited from="[2004] HCA 58">whether claim was "fairly based" on the matter described in the specification within s 40(3) of the patents act 1990 (cth) or travelled beyond it</citphrase>
<citphrase id="cp2.7" type=cited from="[2004] HCA 58">whether test of fair basing involves consideration of "merit", "inventive step", "technical contribution to the art" or general "fairness"</citphrase>
<citphrase id="cp2.8" type=cited from="[2004] HCA 58">whether grounds of invalidity under patents act must be kept distinct.</citphrase>
<citphrase id="cp3.0" type=cited from="[2004] FCA 323">intellectual property</citphrase>
<citphrase id="cp3.1" type=cited from="[2004] FCA 323">patents</citphrase>
<citphrase id="cp3.2" type=cited from="[2004] FCA 323">patent for a system for the preparation of fluid intended for medical procedures such as haemodialysis</citphrase>
<citphrase id="cp3.3" type=cited from="[2004] FCA 323">respondent found to have infringed the patent in suit</citphrase>
<citphrase id="cp3.4" type=cited from="[2004] FCA 323">cross claim</citphrase>
<citphrase id="cp3.5" type=cited from="[2004] FCA 323">whether lack of novelty, lack of utility, lack of sufficiency of description, lack of fair basing and obviousness.</citphrase>
<citphrase id="cp8.0" type=cited from="[1994] FCA 1168">patents</citphrase>
<citphrase id="cp8.1" type=cited from="[1994] FCA 1168">petty patent</citphrase>
<citphrase id="cp8.2" type=cited from="[1994] FCA 1168">computer program</citphrase>
<citphrase id="cp8.3" type=cited from="[1994] FCA 1168">word processing of chinese language characters</citphrase>
<citphrase id="cp8.4" type=cited from="[1994] FCA 1168">whether manner of manufacture</citphrase>
<citphrase id="cp8.5" type=cited from="[1994] FCA 1168">novelty</citphrase>
<citphrase id="cp8.6" type=cited from="[1994] FCA 1168">fair basing</citphrase>
<citphrase id="cp8.7" type=cited from="[1994] FCA 1168">infringement</citphrase>
<citphrase id="cp8.8" type=cited from="[1994] FCA 1168">anticipation by alleged infringement.</citphrase>
<citphrase id="cp9.0" type=cited from="[1994] FCA 1065">patents</citphrase>
<citphrase id="cp9.1" type=cited from="[1994] FCA 1065">validity</citphrase>
<citphrase id="cp9.2" type=cited from="[1994] FCA 1065">whether claims in standard patent fairly based on provisional specification</citphrase>
<citphrase id="cp9.3" type=cited from="[1994] FCA 1065">whether method of treatment of disease or other abnormality in human being may be made the subject of a valid grant of letters patent.</citphrase>
<citphrase id="cp10.0" type=citing from="[2010] FCA 143">patents</citphrase>
<citphrase id="cp10.1" type=citing from="[2010] FCA 143">application for leave to appeal under s 158(2) of the patents act 1990 from a judgment given on an appeal against decisions of a delegate of the commissioner of patents</citphrase>
<citphrase id="cp10.2" type=citing from="[2010] FCA 143">applicable principles</citphrase>
</citphrases>
<citances>
<sentence id="cs0" from="[2010] FCA 143">The matter presently before the Court is an application filed on 18 February 2009 for leave to appeal, pursuant to s 158(2) of the Patents Act 1990 (Cth) ('the Act'), to a Full Court against a judgment of a judge of this Court given on 28 January 2009 (see Sunnyfield Association v Cronk [2009] FCA 33 ; (2009) 80 IPR 300 , on an appeal by the applicant against decisions of a delegate of the Commissioner of Patents under s 60(4) of the Act, of 25 January 2007, rejecting oppositions by the applicant under s 59 of the Act to the grant of standard patents covered by Patent Application No. 716550 (first decision) and Patent Application No. 759725 (second decision). </sentence>
</citances>
<legistitles>
<title id="l0">FEDERAL COURT RULES </title>
</legistitles>
</case>